ACRV compared with SGP: revenue, margins and what each company keeps, and the suppliers and customers both name

ACRVAcrivon Therapeutics, Inc.

Mkt capRevenueRevenue

SGPSpyGlass Pharma, Inc.

Mkt capRevenueRevenue

Compare

ACRVAcrivon Therapeutics, Inc.

SGPSpyGlass Pharma, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only ACRV 7

LLYEli Lilly & Company (Lilly)supplier

—Akoyaunlistedsupplier

—MD Anderson Cancer Center (MDACC)unlistedsupplier

—Moffitt Cancer Centerunlistedsupplier

3 more · ACRV chain ›

Shared 0

No shared counterparties.

Only SGP 1

—Regents of the University of Colorado (CU)unlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

ACRVAcrivon Therapeutics, Inc.

1.57▼−9.84%

Mkt cap$13.1M

SGPSpyGlass Pharma, Inc.

33.25▼−3.48%

Regular sessionNov 5 '26

Mkt cap$1.2B

Compare

Regular sessionNov 5 '26

ACRVAcrivon Therapeutics, Inc.

SGPSpyGlass Pharma, Inc.

1.57▼−9.84%

Price

33.25▼−3.48%

$13.1M

Mkt cap

$1.2B

ACRV1.57▼−9.84%vsSGP33.25▼−3.48%Regular sessionNov 5 '26